© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Longchain n–3 polyunsaturated fatty acids and blood vessel function
CSIRO Health Sciences and Nutrition, Kintore Avenue, P.O. Box 10041, Adelaide BC, SA 5000, Australia
* Corresponding author. Tel.: +61-8-8303-8889; fax: +61-8-8303-8899 mahinda.abeywardena{at}hsn.csiro.au
The cardiovascular health benefits of longchain n–3 polyunsaturated fatty acids (PUFAs) have been reported to exert at several different cellular control mechanisms. These include, effects on lipoprotein metabolism, haemostatic function, platelet/vessel wall interactions, anti-arrhythmic actions and also inhibition of proliferation of smooth muscle cells and therefore growth of the atherosclerotic plaque. Fish oil feeding has also been found to result in moderate reductions in blood pressure and to modify vascular neuroeffector mechanisms. The majority of such cardiovascular benefits of n–3 PUFAs are likely to be mediated in the vascular wall and at the vascular endothelium level, since this monolayer of cells plays a central role in the regulation and maintenance of cardiovascular homeostasis and function. While these processes include endothelium-derived vasorelaxant and vasoconstrictor compounds, the vascular endothelium also plays host to many receptors, binding proteins, transporters and signalling mechanisms. Accordingly, endothelial dysfunction, which underlies many cardiovascular disease conditions, can trigger acute vascular events including vasospasm, thrombosis or restenosis leading to ischaemia. The longchain n–3 PUFAs have been reported to possess several properties that may positively influence vascular function. These include favourable mediator profiles (nitric oxide, eicosanoids) that influence vascular reactivity, change in vascular tone via actions on selective ion channels, and maintenance of vascular integrity. In addition to direct effects on contractility, n–3 PUFAs may affect vascular function, and the process of atherogenesis, via inhibition of vascular smooth muscle cell proliferation at the gene expression level, and by modifying expression of inflammatory cytokinesis and adhesion molecules. Collectively, these properties are consistent with pleiotropic actions of longchain n–3 PUFAs, and may explain the beneficial cardiovascular protection of this family of fatty acids that have been clearly evident through epidemiological data as well from more recent large-scale clinical trials.
KEYWORDS Endothelial function; Nitric oxide; Prostaglandins; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. R Miller III, S. P Juraschek, L. J Appel, M. Madala, C. A. Anderson, J. Bleys, and E. Guallar The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morin, M. Sirois, V. Echave, E. Rizcallah, and E. Rousseau Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L130 - L139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Delbosc, M. Glorian, A.-S. Le Port, G. Bereziat, M. Andreani, and I. Limon The Benefit of Docosahexanoic Acid on the Migration of Vascular Smooth Muscle Cells Is Partially Dependent on Notch Regulation of MMP-2/-9 Am. J. Pathol., May 1, 2008; 172(5): 1430 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Patten, M. J. Adams, J. A. Dallimore, and M. Y. Abeywardena Depressed Prostanoid-Induced Contractility of the Gut in Spontaneously Hypertensive Rats (SHR) Is Not Affected by the Level of Dietary Fat J. Nutr., November 1, 2004; 134(11): 2924 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T Erkkila, S. Lehto, K. Pyorala, and M. I. Uusitupa n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease Am. J. Clinical Nutrition, July 1, 2003; 78(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soinio, M. Laakso, S. Lehto, P. Hakala, and T. Ronnemaa Dietary Fat Predicts Coronary Heart Disease Events in Subjects With Type 2 Diabetes Diabetes Care, March 1, 2003; 26(3): 619 - 624. [Abstract] [Full Text] [PDF]
|
|